DIAGNOS (CVE:ADK) Reaches New 1-Year High – Time to Buy?

DIAGNOS Inc. (CVE:ADK) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$0.42 and last traded at C$0.40, with a volume of 183300 shares trading hands. The stock had previously closed at C$0.39.

DIAGNOS Stock Performance

The stock has a 50 day moving average price of C$0.27 and a two-hundred day moving average price of C$0.26. The company has a debt-to-equity ratio of 204.05, a current ratio of 1.49 and a quick ratio of 0.68. The company has a market capitalization of C$48.77 million, a price-to-earnings ratio of -10.12 and a beta of -0.14.

Insider Activity

In other news, Director Robert Dunn purchased 200,000 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were acquired at an average price of C$0.30 per share, with a total value of C$60,000.00. Following the completion of the purchase, the director directly owned 2,117,778 shares of the company’s stock, valued at C$635,333.40. The trade was a 10.43% increase in their position. Insiders acquired a total of 328,571 shares of company stock worth $96,000 over the last quarter. Corporate insiders own 16.81% of the company’s stock.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.